Physician

Craig J Badolato, MD

According to 2025 Medicare claims, Craig Badolato, MD (NPI: 1013998970) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is CANCER CARE CENTERS OF BREVARD INC (NPI: 1467551762; TIN: 593169766) and primary practice location at 32901-3119. Badolato is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Badolato's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 381 traditional Medicare patients, billed 136,029 HCPCS/CPT codes, and received $2,299,355 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,402 prescription claims across 208 beneficiaries totaling $3,695,848 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 32 claims. Open Payments data shows 233 records totaling $6,124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $926,721 to $2,299,355. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,447,264 to $3,695,848. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,015 and ending at $1,298.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $926,721 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,151,729 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,420,293 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,169,455 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,286,486 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,609,198 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,388,744 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,775,709 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,186,566 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,299,355 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201537281,090$926,721
201630473,381$1,151,729
201727391,589$1,420,293
201830278,922$1,169,455
2019353116,488$2,286,486
2020367135,794$2,609,198
2021388120,969$2,388,744
2022377146,994$2,775,709
2023362139,789$2,186,566
2024381136,029$2,299,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.4M2015 Drug cost: $1,447,264 (USD; Tot_Drug_Cst)2016 Drug cost: $1,962,009 (USD; Tot_Drug_Cst)2017 Drug cost: $1,692,959 (USD; Tot_Drug_Cst)2018 Drug cost: $2,302,651 (USD; Tot_Drug_Cst)2019 Drug cost: $2,649,084 (USD; Tot_Drug_Cst)2020 Drug cost: $3,668,467 (USD; Tot_Drug_Cst)2021 Drug cost: $4,431,363 (USD; Tot_Drug_Cst)2022 Drug cost: $4,298,495 (USD; Tot_Drug_Cst)2023 Drug cost: $3,998,060 (USD; Tot_Drug_Cst)2024 Drug cost: $3,695,848 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015101662$1,447,264
2016110806$1,962,009
2017107809$1,692,959
2018133813$2,302,651
20191981,210$2,649,084
20201911,206$3,668,467
20211871,273$4,431,363
20221971,259$4,298,495
20231741,253$3,998,060
20242081,402$3,695,848

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$10K$21K2015 Medicare payment: $3,842 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $20,636 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,007 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,289 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,702 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R45$3,842
2016N/R61$20,636
2017N/R13$10,007
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R34$1,289
2022N/R68$2,702
2023N/R32$1,248
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8787$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more265617$99
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's246486$13
36415Insertion of needle into vein for collection of blood sample237587$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count261795$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide421,162$823,288
LenalidomideLenalidomide421,148$616,654
XtandiEnzalutamide30900$420,491
IbrancePalbociclib23644$357,670
ImbruvicaIbrutinib24672$352,800

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.233$6,124AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Craig J. Badolato, MD?

Tedicare shows public-source Medicare data for Craig J. Badolato, MD (NPI 1013998970), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Craig J. Badolato, MD have ACO affiliation data?

Craig J. Badolato, MD is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Craig J. Badolato, MD?

Craig J. Badolato, MD is linked to CANCER CARE CENTERS OF BREVARD INC (billing NPI 1467551762) in the available physician profile data.

Does Craig J. Badolato, MD have Open Payments data?

Craig J. Badolato, MD has 233 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.